| name | ata-preop-ch-lt4 |
| description | This skill guides perioperative levothyroxine management for adults with preoperative central hypothyroidism undergoing non-emergency surgery. Trigger phrases include "preoperative central hypothyroidism patient requiring non-emergency surgery" and "use when managing preoperative CH patient". |
Administer levothyroxine before and during non-emergency surgery with preoperative central hypothyroidism
STEP 1 — Gather Information
Confirm preoperative central hypothyroidism: measure serum fT4 and TSH; low fT4 with low/normal/mildly elevated TSH in the setting of pituitary disease. Verify surgery is non-emergency. Assess for adrenal insufficiency if clinically indicated (e.g., morning cortisol, ACTH stimulation test) to avoid precipitating crisis. End with: proceed to rule‑in/out.
STEP 2 — Rule In / Rule Out
Is central hypothyroidism confirmed by low fT4 with inappropriate TSH? If yes, move to dose planning; if no, rule out CH and evaluate alternative causes of thyroid dysfunction before considering L‑4 therapy.
STEP 3 — Classify or Stratify
Estimate starting L‑T4 dose: 1.6 µg/kg/d total daily dose, rounded to nearest practical tablet strength; adjust downward for age >60 y, comorbidities, or if fT4 is mid‑reference, upward if symptomatic or fT4 low‑normal. End with: decide on specific preoperative L‑T4 dose.
STEP 4 — Decide
Initiate L‑T4 at the calculated dose at least 24 h before surgery, continue the same dose throughout the perioperative period, and obtain fT4 6–8 weeks postoperatively to assess adequacy and adjust if needed.
Clinical Guardrails / Mimics / Pitfalls
Do not use TSH to guide L‑T4 dosing in CH; avoid L‑T3, thyroid extracts, or combination products; ensure adrenal insufficiency is excluded or covered with stress‑dose glucocorticoids before starting L‑T4 to prevent adrenal crisis; avoid over‑replacement (fT4 above upper‑half of reference) which may increase bone‑turnover and cardiac risk; monitor for signs of over‑ or under‑replacement (e.g., weight change, fatigue, palpitations).
Concrete Clinical Example
A 58‑year‑old man with a known pituitary macroadenoma presents for elective transsphenoidal resection. Pre‑op labs show fT4 0.6 ng/dL (low) and TSH 2.1 µIU/mL (low‑normal). Weight 80 kg → starting L‑T4 1.6 µg/kg/d ≈ 128 µg daily (two 64 µg tablets). He takes this dose morning of surgery and continues unchanged through hospital stay. Six weeks post‑op fT4 is 1.2 ng/dL (mid‑reference); dose maintained.
Source: Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2118
